Munich Re Canada Life press releases

Normal view (turn off text only mode)
You are here:

18 September 2018

Milliman Risk Score 2.0 – stratifying mortality risk using prescription drug information

Our colleagues at Munich Re, U.S. assessed the effectiveness of the Milliman Rx Risk Score 2.0, a predictive modeling tool developed and owned by Milliman that assesses mortality risk using an individual’s prescription drug information. Our findings demonstrated that the enhanced Rx Risk Score 2.0 is indeed predictive of mortality for the U.S. insurance applicant population.

Contact

June Quah
Assistant Vice President, Integrated Analytics


Main Navigation
Service Men
Accessibility

© Copyright 2017 Munich Reinsurance Company Canada Branch (Life).

Note


This publication is available exclusively to Munich Re clients. Please contact your Client Manager.